The ROLOCIAM brand, founded in 2014 (United States), from
142 sister brands
and 17478 competing brands.
ROLOCIAM is owned by Amgen, listed on the stock exchange of New York
ROLOCIAM belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.